Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration?

Diabetologia

Volumn 48, Issue 11, 2005, Pages 2221-2228

  Meier, J J ^a   Bhushan, A ^a   Butler, A E ^a   Rizza, R A ^b   Butler, P C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmunity; Beta cell apoptosis; Insulin secretion; Islet regeneration; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; BLOOD GLUCOSE MONITORING; CELL COUNT; CELL DIVISION; CELL LOSS; CELL REGENERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETOGENESIS; DISEASE DURATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MACROPHAGE ACTIVATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; APOPTOSIS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL COUNT; DIABETES MELLITUS, TYPE 1; FEMALE; FIBROSIS; HUMANS; INSULIN-SECRETING CELLS; MACROPHAGES; MALE; MIDDLE AGED; PANCREAS; REGENERATION; T-LYMPHOCYTES;

EID: 27744603796     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1949-2     Document Type: Article

References (36)

1. Warren S, Root HF (1925) The pathology of diabetes, with special reference to pancreatic regeneration. Am J Pathol 1:415-430
2. Stansfield OH, Warren S (1928) Inflammation involving the islets of Langerhans in diabetes. N Engl J Med 198:686-687
3. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
4. Junker K, Egeberg J, Kromann H, Nerup J (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A 85:699-706
5. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251-261
6. Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371
7. Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762
8. Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227
9. Robertson RP (2004) Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 350:694-705
10. Cheung AT, Dayanandan B, Lewis JT et al (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290:1959-1962
11. Halban PA (2004) Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat Cell Biol 6:1021-1025
12. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358221-229
13. Kurrer MO, Pakala SV, Hanson HL, Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-218
14. Jorns A, Kubat B, Tiedge M et al (2004) Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch 444:183-189
15. Butler AE, Janson J, Bonner-Weir S et al (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
16. Imagawa A, Hanafusa T, Tamura S et al (2001) Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50:1269-1273
17. Faber OK, Binder C (1977) B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Diabetologia 13:263-268
18. Madsbad S, Krarup T, Reguer L, Faber OK, Binder C (1981) Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Diabetologia 20:530-534
19. Madsbad S (1983) Prevalence of residual B cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 24:141-147
20. The DCCT Research Group (1987) Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-36
21. The Diabetes Control and Complications Trial Research Group (1998) Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 128:517-523
22. Kolb H, Gale EA (2001) Does partial preservation of residual beta-cell function justify immune intervention in recent onset type I diabetes? Diabetologia 44:1349-1353
23. Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1):S119-S124
24. Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
25. Bach JF (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542
26. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46
27. Wang RN, Bouwens L, Kloppel G (1996) Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 39:548-557
28. Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314
29. Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633
30. Ritzel RA, Butler PC (2003) Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52:1701-1708
31. Lipsett M, Finegood DT (2002) Beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 51:1834-1841
32. Edlund H (2002) Pancreatic organogenesis - developmental mechanisms and implications for therapy. Nat Rev Genet 3:524-532
33. Vacca JB, Henke WJ, Knight WA Jr (1964) The exocrine pancreas in diabetes mellitus. Ann Intern Med 61:242-247
34. Lankisch PG, Manthey G, Otto J et al (1982) Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 25:211-216
35. Kobayashi T, Nakanishi K, Kajio H et al (1990) Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:363-370
36. Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-461